ANI Pharmaceuticals Inc (ANIP)
65.41
-0.68
(-1.03%)
USD |
NASDAQ |
Apr 24, 16:00
65.41
0.00 (0.00%)
After-Hours: 18:48
ANI Pharmaceuticals Debt to Equity Ratio: 0.6243 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.6243 |
| September 30, 2023 | 0.6287 |
| June 30, 2023 | 0.6585 |
| March 31, 2023 | 0.8434 |
| December 31, 2022 | 0.8463 |
| September 30, 2022 | 0.8517 |
| June 30, 2022 | 0.8516 |
| March 31, 2022 | 0.8297 |
| December 31, 2021 | 0.8011 |
| September 30, 2021 | 1.055 |
| June 30, 2021 | 1.067 |
| March 31, 2021 | 0.9004 |
| December 31, 2020 | 0.9488 |
| September 30, 2020 | 0.9633 |
| June 30, 2020 | 0.9941 |
| March 31, 2020 | 0.994 |
| December 31, 2019 | 0.8729 |
| September 30, 2019 | 0.8756 |
| June 30, 2019 | 0.8942 |
| March 31, 2019 | 0.9208 |
| December 31, 2018 | 0.9278 |
| September 30, 2018 | 1.069 |
| June 30, 2018 | 1.105 |
| March 31, 2018 | 1.127 |
| December 31, 2017 | 1.153 |
| Date | Value |
|---|---|
| September 30, 2017 | 0.8276 |
| June 30, 2017 | 0.8745 |
| March 31, 2017 | 0.8855 |
| December 31, 2016 | 0.7111 |
| September 30, 2016 | 0.7037 |
| June 30, 2016 | 0.7143 |
| March 31, 2016 | 0.7192 |
| December 31, 2015 | 0.7086 |
| September 30, 2015 | 0.7389 |
| June 30, 2015 | 0.7603 |
| March 31, 2015 | 0.775 |
| December 31, 2014 | 0.7622 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.3138 |
| December 31, 2012 | 0.2798 |
| September 30, 2012 | 0.2352 |
| June 30, 2012 | 0.3389 |
| March 31, 2012 | 0.2762 |
| December 31, 2011 | 0.4585 |
| September 30, 2011 | 0.4638 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.6243
Minimum
Dec 2023
1.067
Maximum
Jun 2021
0.8684
Average
0.8729
Median
Dec 2019
Debt to Equity Ratio Benchmarks
| Ligand Pharmaceuticals Inc | 0.00 |
| ADMA Biologics Inc | 0.9659 |
| Dentsply Sirona Inc | 0.6432 |
| Allogene Therapeutics Inc | 0.00 |
| Vanda Pharmaceuticals Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 904.42M |
| Total Liabilities (Quarterly) | 446.82M |
| Shareholders Equity (Quarterly) | 457.60M |
| Current Ratio | 3.573 |
| Net Debt Paydown Yield | 0.02% |